In reply: Belton is correct that “safety and efficacy of medications” is a matter for the Therapeutic Goods Association. The dispute was whether such limited criteria can meaningfully assess a drug designed to take life.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
